Position in VCEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,397,078
+$1,711,688 QoQ
Shares Held
98,833
+18.4% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. VCEL ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,397,078 | 98,833 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,685,390 | 83,475 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $4,067,111 | 112,944 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,991,285 | 95,052 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,987,870 | 93,722 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,462,421 | 77,598 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,842,325 | 69,975 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,645,355 | 62,612 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,022,710 | 65,883 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,358,148 | 64,555 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,325,936 | 65,317 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,953,446 | 88,110 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,555,623 | 94,640 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,581,477 | 88,045 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,397,730 | 53,065 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,486,886 | 64,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,662,457 | 66,023 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $12,330,380 | 322,616 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,551,043 | 319,365 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $57,569,504 | 1,179,703 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $53,253,268 | 1,014,348 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $57,516,189 | 1,035,395 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $37,393,548 | 1,210,931 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $22,774,888 | 1,229,082 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $16,714,445 | 1,209,439 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $8,907,764 | 971,403 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||